ISCT MSC committee statement on the US FDA approval of allogenic bone-marrow mesenchymal stromal cells
- DOI
- 10.1016/j.jcyt.2025.01.005
- Published
- 2025-04
- Container
- Cytotherapy
- Publisher
- Elsevier BV
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1016/j.jcyt.2025.01.005,
title = {ISCT MSC committee statement on the US FDA approval of allogenic bone-marrow mesenchymal stromal cells},
author = {Katarina Le Blanc and Francesco Dazzi and Karen English and Dominique Farge and Jacques Galipeau and Edwin M. Horwitz and Nadir Kadri and Mauro Krampera and Manoj Mathew Lalu and Jan Nolta and Nikita M. Patel and Yufang Shi and Daniel J. Weiss and Sowmya Viswanathan},
year = {2025},
journal = {Cytotherapy},
doi = {10.1016/j.jcyt.2025.01.005},
url = {https://doi.org/10.1016/j.jcyt.2025.01.005}
}RIS
TY - JOUR TI - ISCT MSC committee statement on the US FDA approval of allogenic bone-marrow mesenchymal stromal cells AU - Katarina Le Blanc AU - Francesco Dazzi AU - Karen English AU - Dominique Farge AU - Jacques Galipeau AU - Edwin M. Horwitz AU - Nadir Kadri AU - Mauro Krampera AU - Manoj Mathew Lalu AU - Jan Nolta AU - Nikita M. Patel AU - Yufang Shi AU - Daniel J. Weiss AU - Sowmya Viswanathan PY - 2025 JO - Cytotherapy DO - 10.1016/j.jcyt.2025.01.005 UR - https://doi.org/10.1016/j.jcyt.2025.01.005 ER -
APA
Blanc, K. L., Dazzi, F., English, K., Farge, D., Galipeau, J., Horwitz, E. M., Kadri, N., Krampera, M., Lalu, M. M., Nolta, J., Patel, N. M., Shi, Y., Weiss, D. J., & Viswanathan, S. (2025). ISCT MSC committee statement on the US FDA approval of allogenic bone-marrow mesenchymal stromal cells. Cytotherapy. https://doi.org/10.1016/j.jcyt.2025.01.005
Source records
- crossref · retrieved 2026-09-27T09:41:17.301Z